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1206-148 Impact  of  Aort ic  Stiffness on the Risk of Ischemic 
Stroke in Elder Patients 
Keniehi Sueioka. Robert R. Sciacca, Takeshi Hozumi, Yumiko Miyake, Inna ~tova, 
Gabdelle Gaspard, Ralph L Saoco, Shunichi Homma, Marco R. Di Tullio, Columbia 
University, New York, New York. 
Background: Large aortic atheromas (AA) in the proximal aorta detected by transesoph- 
ageal echocardiography (TEE) are associated with increased risk of ischemic stroke in 
the elderly. The atherosclerotic process also affects aortic distensibility, which can also 
be assessed by TEE. However, little is known about the relation between aortic stiffness 
and stroke risk. The purpose of this study was to evaluate the possible association of 
aortic stiffness with ischemic stroke, as well as the relationship between aortic stiffness 
and AA. 
Methods: We performed TEE in 34 elderly patients with acute ischemic stroke (age 68.6 
+/- 8.6 years, 14 men and 20 women) and in 30 consecutive control subjects (age 66.2 +/ 
- 9.0 years, 15 men end 15 women). The presence and maximum thickness of AA in the 
aortic arch was recorded. Maximum (Dmax) and minimum (Dmin) diameter of the proxi- 
mal descending thoracic aorta during a cardiac cycle was measured on TEE-guided M- 
mode, and the blood pressure (BP) by cuff sphygmomanometry. Aortic stiffness index (B) 
was calculated as follows: 8 = In (systolic BP / diastolic BP) / ([Dmax-Dmin] / Dmin), 
where In is natural logarithm. The association of 8 and AA thickness with ischemic stroke 
was evaluated by logistic regression analysis after adjustment for potential confounders 
(age, gender, hypertension, diabetes mellitus, hypercholesteromia, cigarette smoking, 
coronary artery disease). 
Reaulte: (3. was significantly higher in stroke patients than in controls (10.1 +/- 5.2 vs. 5.9 
+/- 4.0, p<0.001), as was AA thickness (3.7±2.6 mm vs. 2.4±2.2 ram, p<0.05). In stroke 
patients, ~ correlated with AA thickness (r=0.35, p=0.04). When AA thickness and other 
potential confounders were included in a multivariate analysis, f3 was found to be inde- 
pendently associated with ischemic stroke (odds ratio 1.3 per unit increase, 95% confi- 
dence interval 1.1-1.6). 
Conclusion: 1) Aortic stiffness is associated with ischemic stroke, independent of AA 
thickness. 2) Aortic stiffness index may add prognostic information to AA thickness when 
assessing the risk of ischemic stroke in the elderly. 
1206-171 At tenuat ion  of  Biological Compensatory Action of  
Cardiac Natriuretic Peptide System With Aging: Uti l i ty 
and LimltaUon of Plasma Brain Natriuretic Peptide 
Measurements in the Elderly 
Keisuke Kawai. Katsuya Hata, Katsuji Tanaka, Yoshihise Kubota, Ryuji Inoue, Ichiro 
Nakayama, Eisaku Masuda, Mitsuhiro Yokoyama, Toshiyuki Miyazaki, Kanzaki Genera/ 
Municipal Hospital Hyogo, Japan, Kobe University Graduate School of Medicine, Kobe, 
Japan. 
Background: Plasma brain natriuretic peptide (BNP) level is a sensitive and specific 
marker of left ventricular (LV) function, but the meaning of BNP in the elderly remains to 
be elucidated. 
Methods: 282 subjects with creatinine level _<1.5 mg/ml were divided into three groups; 
Those under 70 years old (Group 1), those 70 to 78 years (Group 2), and those over 78 
years (Group 3). Plasma BNP, blood urea nitrogen, creatinine, clinical and echocardio- 
graphic data were evaluated. In addition, biological makers for BNP (cGMP) and for prox- 
imal tubule function [serum 132-microglobulin (82M)] were also evaluated. 
Reeulte: Clinicopathological characteristics in 3 groups are shown in Table. Using multi- 
variate analysis, predictors for BNP in Group 2 were LV mass, E/A and presence of val- 
vular heart disease (VHD); Whereas FJ2M, systolic blood pressure, presence of VHD or 
atrial fibrillation and use of angiotensin converting enzyme-inhibitors were predictors in 
Group 3. The molar ratio of cGMP to BNP was significantly decreased with aging (Fig- 
ure). Significant independent predictors of cGMP were BNP and use of nitrates in Group 
2, and BNP, creatinine and use of digitalis in Group 3. 
Conclusions: Measurements of BNP could be valuable in detecting LV remodeling, LV 
diastolic dysfunction and VHD even in the elderly patients. However, we should utilize the 
BNP level carefully in those over 78 years, because BNP and cGMP may be affected by 
renal dysfunction, and compensation of natriuretic peptide system will be attenuated with 
aging. 
Table. Clinicopathblogical characteristics in three Figure. cGMP/BNP molar ra'do 
groups 
Vanable Group I Group 2 Group 3 in three groups 
(n=124) (n=78) (n=8O) 
Age 59_+9 74_+3* 84_+4"1" 
LV EDD (mm) 46_+5 46_+6 44+7 
%FS (%) 39_+6 39_+6 37_+7 
LV mass (g) 155_+48 167_+63 152_+51 
E/A 0.90_+0.27 0.77+0.24* 0.66_+0.22"1" 
BN P (pg/ml) 22 _+ 26 77 + 147" 87 -+ 93* 
cGMP (pmol/ml) 4.1 -+ 2.0 5.8 _+ 3.4* 5.5 _+ 2.4* 
BUN (mg/dl) 15+4 17+4" 18+5" 
Creatinine 0,8_+0.2 0.8-+0.2 0.8-+0.2 Group1 Group2 Group3 
1~2M (mgJl) 1,6+0,4 1.9+0.6" 2.5-+0.8"1" (< 70yrs.) (70-/3yes.) (>/31n.) 
VHD (%) 1 7* 19" 
Data are mean -+ SD. *:p<0.0186 vs Group 1, Data are mean "+- SEM 
1": p<0.0166 vs Group 2 by ANOVA *: P < 0,0001 vs Group 1 
BUN = blood urea nitrogen; 
F.JA = early-to-atrial transmitral peak wdocity ratio; 
EDO = end-diastolic diameter; FS = fl"actioning 
shortening 
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1206-172 Prognostic Significance of Elevated Plasma Brain 
Natrluretl¢ PolypepUde in Patients With Chronic Renal 
Failure Treated With Hemodialyais 
Shin-ich Inoue, Toshio Shimeda, Yo Murakami, Ko Nakamura, Hiromi Shimizu, Harumi 
Katoh, Yoke Ohta, Nobuyuki Takahashi, Nobuyuki Oyake, Yutaka Ishibashi, Keiko 
Suzuki, The 4th Department of Internal Medicine, Shimane Medical Universi~ Izumo, 
Japan. 
Background: Cardiovascular and carebrovaacular disease are one of the most impor- 
tant complications for prognosis in dialysis patients, tn the general population, brain natri- 
uretic polypeptide (BNP) has been shown to reflect prognosis of patients with congestive 
heart failure, however, the clinical implication on high levels of plasma BNP remains 
unclear in dialysis patients. The goal of this study is to test whether plasma BNP levels 
can predict prognosis of dialysis patients. 
Methods: One hundred and one patients without overt heart failure, who had undertaken 
with hemodialysis 3 times a week, were prospectively enrolled. All patients were followed 
for 40 months. 
Finding: A total of 20 patients died of cardiovascular or carebrovascular disease. Multi- 
variate analysis was performed using Cox's proportional hazard model with end-points of 
death. Among plasma BNP, atrial natriuretic polypeptide (ANP), the other clinical bio- 
chemical and echocardiographic parameters tested with multivariate analysis, post-dialy- 
sis plasma BNP level (median: 123 pg/mt) was the most significant independent predictor 
of mortality (p=0.0055). Kaptan-Meier analysis showed poor long-term prognosis in 
patients with post-dialysis plasma BNP level of >123 pg/ml. 
Interpretation: Plasma BNP levels after hemodialysis may be a useful parameter pre- 
dicting mortality in patients treated with dialysis. 
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1206-1 73 Depressive Symptoms and Heart Rate Variabi l i ty in 
Postmenopausal Women: An Ancillary Study to the 
Women's Health In i t iat ive 
Chin K, Kim, Beth A. Bartholomew, David Sheffield, Michelle Marsh, Tammy Dicken, 
Jackie Woodard, David Curb, Albert Oberman, Judith Hsia, Julius Gardin, Nathan Wong, 
Bruce Barton, Robert McMahon, David S. Sheps, University of Florida, Gainesville, 
Flodda. 
Background: Depressive symptoms have been associated with increased cardiac mor- 
bidity and mortality. Lower heart rate variability (HRV) has been shown to increase risk 
for cardiac events in both normal and coronary artery disease patients and may help 
explain these relationships. However, the relationship between depressive symptoms 
and HRV has been inconsistent across studies. 
Methods: As an ancillary study to the Women's Health Initiative, 2699 postmenopausal 
women, aged between 50 and 83 years, were enrolled for further evaluation with 24 hour 
ambulatory electrocardiographic monitoring. A shortened Center for Epidemiologic Stud- 
ies-Depression scale (CES-D) and Diagnostic Interview Schedule (DIS) were adminis- 
tered. 
Results: Two hundred and eighty women (10.4 %) had depressive symptoms as mea- 
sured by the CES-D/DIS. Women with depressive symptoms had lower HRV and higher 
average heart rate (HR) as seen in the table below. All differences remained significant 
(p< 0.02) after adjusting for age. 
Depressive Symptoms 
Means (SD) Present Absent p value 
Mean HR 77.1 (9.6) 75.5 (8.5) 0.008 
SDNN 113.4 (30.7) 118.8 (32.2) 0.008 
ASDNN 42.5 (14.2) 44.6 (16.6) 0.018 
SDANN 102.5 (29.9) 108.2 (32.6) 0.005 
Mean HR- average heart rate 
SDNN- standard deviation of all normal R-R intervals 
ASDNN- average of all 5 minute standard deviations of N-N intervals 
SDANN- standard deviation of the 5 minute average of N-N intervals 
Conclusion: Women with depressive symptoms on the CES-D/DIS had significant 
reductions in heart rate variability and increases in heart rates, suggesting increased 
sympathetic tone. This may help explain the increased cardiac morbidity and mortality 
associated with depression in other studies. 
